More info:

• Popular Products

  Viagra Cialis Viagra Professional Cialis Professional Amoxil Prednisolone Lasix Propecia Levitra

• Celexa

  Product Monograph: Celexa (Citalopram Hydrobromide) Celexa, with the active ingredient citalopram hydrobromide, is a selective serotonin reuptake inhibitor (SSRI) classified as an antidepressant. It is a cornerstone in the modern pharmacologic management of major depressive disorder (MDD) and several anxiety-related conditions. Since its introduction, it has been distinguished by a relatively selective mechanism and a generally favorable tolerability profile compared to older antidepressant classes like tricyclics (TCAs) and monoamine oxidase inhibitors (MAOIs).

• Obelit

  Product Description: Obelit is a class IIa medical device, specifically a non-invasive bioresonance therapy system designed for the adjunctive management of chronic pain syndromes, functional somatic disorders, and stress-related conditions. It operates on the principle of endogenous biofeedback, utilizing low-intensity electromagnetic fields to interact with the body’s own bioelectrical information. Think of it not as adding energy, but as helping the body “tune” its own signaling. It’s registered with the relevant EU notified body and carries the CE mark for its indicated medical purposes.

• Erythromycin

  Erythromycin is a macrolide antibiotic with a broad spectrum of antibacterial activity. It is derived from the bacterium Saccharomyces erythraeus and has been a cornerstone in antimicrobial therapy since its introduction in the 1950s. Primarily used to treat bacterial infections, it works by inhibiting bacterial protein synthesis. Its applications range from common respiratory and skin infections to specific uses in gastrointestinal motility disorders and perioperative prophylaxis. This monograph provides a comprehensive, evidence-based overview of erythromycin, detailing its pharmacology, clinical applications, safety profile, and practical considerations for use.

• Aciphex

  Aciphex (Rabeprazolo): Inibitore Selettivo della Pompa Protonica per il Controllo Acido Gastrico - Monografia Basata sull’Evidenza Aciphex, il cui principio attivo è il rabeprazolo sodico, rappresenta un cardine nella terapia soppressiva dell’acido gastrico. Appartiene alla classe degli inibitori della pompa protonica (PPI), farmaci che hanno rivoluzionato la gestione di una vasta gamma di disturbi acidi-correlati. A differenza degli antagonisti dei recettori H2, che bloccano solo uno dei percorsi di stimolazione della cellula parietale, gli IPP come Aciphex agiscono sullo step finale e comune della secrezione acida: la pompa protonica H+/K+ ATPasi.

• Dutanol: Neuromodulation Therapy for Refractory Tinnitus - Evidence-Based Review

  Product Description: Dutanol is a non-invasive, Class IIa medical device designed for the symptomatic treatment of chronic, refractory tinnitus. It utilizes a precisely calibrated, low-intensity, alternating current electrical stimulation applied transcutaneously to the auricular branch of the vagus nerve (ABVN) and associated dermatomes of the external ear. The therapy aims to modulate aberrant neuronal activity within central auditory and non-auditory brain networks implicated in tinnitus perception. It is intended for use under the guidance of a qualified healthcare professional, typically within a structured therapeutic protocol.

• Caverta

  Let’s talk about Caverta. In the clinic, when a patient presents with erectile dysfunction (ED), it’s rarely just a standalone issue. It’s a window into vascular health, psychological well-being, and often, a complicating factor in relationships. For years, the introduction of sildenafil citrate revolutionized our approach, moving from invasive interventions to a pill. Caverta is one of the key generic formulations of this molecule I’ve worked with extensively. It’s not a magic bullet, but when used correctly, within the right clinical context, it’s a profoundly effective tool.

• Enclomisign: A Next-Generation Oral SERD for ER+ Breast Cancer - Evidence-Based Review

  Product Description Enclomisign is a novel, non-hormonal, orally administered small molecule therapeutic agent currently under investigation as a selective estrogen receptor degrader (SERD) for the treatment of estrogen receptor-positive (ER+) breast cancer. It is designed to overcome limitations of current endocrine therapies, such as acquired resistance to selective estrogen receptor modulators (SERMs) like tamoxifen and degradation-resistant mutations in the estrogen receptor. Unlike traditional SERDs that are often large molecules with poor oral bioavailability (e.

• Digoxin

  Product Description Digoxin, a cardiac glycoside derived from the foxglove plant (Digitalis lanata), remains a cornerstone in the pharmacological management of specific cardiovascular conditions. Its primary role in modern therapeutics is as a positive inotrope and negative chronotrope, meaning it increases the force of heart muscle contractions while slowing the heart rate. This monograph provides a comprehensive, evidence-based review of digoxin, detailing its mechanism, clinical applications, safety profile, and its nuanced place in contemporary cardiology.

• Galantamine: Cognitive Symptom Management in Alzheimer's Disease - An Evidence-Based Review

  Product Description: Galantamine is a naturally occurring alkaloid, originally isolated from the bulbs of the Galanthus (snowdrop) plant and other species like Narcissus. It functions as a reversible, competitive acetylcholinesterase inhibitor and an allosteric modulator of nicotinic acetylcholine receptors. In clinical practice, it is primarily utilized as a prescription medication for the treatment of mild to moderate Alzheimer’s disease dementia. It is available in both synthetic and plant-derived forms, with common oral formulations including immediate-release and extended-release tablets, as well as oral solutions.